Dr. Reddy's Laboratories launches Amlodipine Besylate and Atorvastatin Calcium Tablets
Published on March 27, 2014 at 5:13 AM
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/40mg and 10/80 mg a therapeutic equivalent generic version of CADUET® (amlodipine Besylate and atorvastatin calcium) tablets, in the US market on March 26, 2014, following the approval by the United States Food & Drug Administration (USFDA).
The CADUET® tablets brand and generic had U.S. sales of approximately $163 Million MAT for the most recent twelve months ending in January 2014 according to IMS Health*.
Dr. Reddy's Amlodipine Besylate and Atorvastatin Calcium Tablets are available in bottle counts of 30 and 90**.
Dr. Reddy's Laboratories Ltd.